ROME ZACHARY (Chief Operating Officer) sold 13.5% of their position (50K shares) of KUVATRIS THERAPEUTICS, INC. on the open market
Open‑market sale worth $27.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/23/2023ACC: 0001062993-23-017018
DirectorOfficer· Chief Operating Officer
Since Aug 2022
-50K
Net shares
Net seller
$27.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−20K
Price / share
$0.58
Trade value
$11.63K
% of position
5.4%
8/21/2023
369.28K→349.28K
Common Stock
Direct
Shares
−30K
Price / share
$0.54
Trade value
$16.24K
% of position
8.6%
8/22/2023
349.28K→319.28K
Total
Net shares
−50K
Net value
-$27.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2023 | S · Sale | −20K | $0.58 | $11.63K | 5.4% | 369.28K | 349.28K |
| Common Stock Direct | 8/22/2023 | S · Sale | −30K | $0.54 | $16.24K | 8.6% | 349.28K | 319.28K |
| Total | −50K | -$27.86K | ||||||
Derivative Transactions0
No derivative transactions reported